Seroprevalence Studies Are Critical Early Pandemic Tools, and They Were Underappreciated During Covid-19. American journal of public health Bendavid, E. 2023: e1-e2

View details for DOI 10.2105/AJPH.2023.307259

View details for PubMedID 36926963